GoingToMeet

Studies demonstrating the role of the immune system in the development and/or prevention of cancer, and elucidating the obstacles limiting an effective immune response to progressing tumors, have suggested strategies for manipulating the immune system to promote eradication of established tumors. This meeting will bring together investigators probing innate and adaptive immune systems, as well as regulatory pathways, to provide a context for developing effective tumor immunotherapies. The major objectives will be as follows: (1) explore the dual roles that components of the immune system can play early in developing malignancies, leading to protection or tumor promotion; (2) examine the mechanisms by which immune responses can be subverted by the malignant process; (3) describe the rationale for and potential benefit of immunotherapeutic strategies currently being explored for modulating adaptive immunity to achieve therapeutic anti-tumor responses; and (4) discuss the rationale for concurrently employing multiple immunosupportive modalities to enhance immunotherapeutic strategies.